BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Telarovic I, Wenger RH, Pruschy M. Interfering with Tumor Hypoxia for Radiotherapy Optimization. J Exp Clin Cancer Res 2021;40:197. [PMID: 34154610 DOI: 10.1186/s13046-021-02000-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 12.5] [Reference Citation Analysis]
Number Citing Articles
1 Arrieta O, Hernández-Pedro N, Maldonado F, Ramos-Ramírez M, Yamamoto-Ramos M, López-Macías D, Lozano F, Zatarain-Barrón ZL, Turcott JG, Barrios-Bernal P, Orozco-Morales M, Flores-Estrada D, Cardona AF, Rolfo C, Cacho-Díaz B. Nitroglycerin Plus Whole Intracranial Radiation Therapy for Brain Metastases in Patients With Non-Small Cell Lung Cancer: A Randomized, Open-Label, Phase 2 Clinical Trial. Int J Radiat Oncol Biol Phys 2023;115:592-607. [PMID: 35157994 DOI: 10.1016/j.ijrobp.2022.02.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Cunningham C, Bolcaen J, Bisio A, Genis A, Strijdom H, Vandevoorde C. Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer. Pharmaceuticals 2023;16:219. [DOI: 10.3390/ph16020219] [Reference Citation Analysis]
3 Sato A, Kraynak J, Marciscano AE, Galluzzi L. Radiation therapy: An old dog learning new tricks. Methods in Cell Biology 2023. [DOI: 10.1016/s0091-679x(23)00036-5] [Reference Citation Analysis]
4 Dwibedi V, Rath SK, Jain S, Martínez-Argueta N, Prakash R, Saxena S, Rios-Solis L. Key insights into secondary metabolites from various Chaetomium species. Appl Microbiol Biotechnol 2023;107:1077-93. [PMID: 36648526 DOI: 10.1007/s00253-023-12365-y] [Reference Citation Analysis]
5 Li R, Zhao W, Wu T, Wang A, Li Q, Liu Y, Xiong H. Tantalum-carbon-integrated nanozymes as a nano-radiosensitizer for radiotherapy enhancement. Front Bioeng Biotechnol 2022;10. [DOI: 10.3389/fbioe.2022.1042646] [Reference Citation Analysis]
6 Guo Z, Xin Y, Yang L, Ran R, Wan G, Ma A, Ren H, Wang Y, Yang X. Biomimetic nanotherapeutics based on oxygen supply and ultrasmall Cu-Se-Au alloy nanoparticles for boosting radio-photothermal ablation of breast cancer. Nano Today 2022;46:101587. [DOI: 10.1016/j.nantod.2022.101587] [Reference Citation Analysis]
7 Najafi A, Keykhaee M, Khorramdelazad H, Karimi MY, Nejatbakhsh Samimi L, Aghamohamadi N, Karimi M, Falak R, Khoobi M. Catalase application in cancer therapy: Simultaneous focusing on hypoxia attenuation and macrophage reprogramming. Biomedicine & Pharmacotherapy 2022;153:113483. [DOI: 10.1016/j.biopha.2022.113483] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Zhou Y, Larnaudie A, Ghannam Y, Ollivier L, Gounane Y, Laville A, Coutte A, Huertas A, Maroun P, Chargari C, Bockel S. Interactions of radiation therapy with common and innovative systemic treatments: Antidiabetic treatments, antihypertensives, lipid-lowering medications, immunosuppressive medications and other radiosensitizing methods. Cancer Radiother 2022:S1278-3218(22)00135-4. [PMID: 36028416 DOI: 10.1016/j.canrad.2022.06.030] [Reference Citation Analysis]
9 Zhu L, Liu J, Qiu M, Chen J, Liang Q, Peng G, Zou Z. Bacteria-mediated metformin-loaded peptide hydrogel reprograms the tumor immune microenvironment in glioblastoma. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121711] [Reference Citation Analysis]
10 Zhang Z, Yi X, Pei Q, Fu Y, Li B, Liu H, Han Z, Chen C, Pang P, Lin H, Gong G, Yin H, Zai H, Chen BT. CT radiomics identifying non‐responders to neoadjuvant chemoradiotherapy among patients with locally advanced rectal cancer. Cancer Medicine. [DOI: 10.1002/cam4.5086] [Reference Citation Analysis]
11 Zhang Z, Liu X, Chen D, Yu J. Radiotherapy combined with immunotherapy: the dawn of cancer treatment. Signal Transduct Target Ther 2022;7:258. [PMID: 35906199 DOI: 10.1038/s41392-022-01102-y] [Reference Citation Analysis]
12 Zhu C, Ma H, He A, Li Y, He C, Xia Y. Exercise in cancer prevention and anticancer therapy: Efficacy, molecular mechanisms and clinical information. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215814] [Reference Citation Analysis]
13 Arthur A, Johnston EW, Winfield JM, Blackledge MD, Jones RL, Huang PH, Messiou C. Virtual Biopsy in Soft Tissue Sarcoma. How Close Are We? Front Oncol 2022;12:892620. [DOI: 10.3389/fonc.2022.892620] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Tan P, Li M, Liu Z, Li T, Zhao L, Fu W. Glycolysis-Related LINC02432/Hsa-miR-98–5p/HK2 Axis Inhibits Ferroptosis and Predicts Immune Infiltration, Tumor Mutation Burden, and Drug Sensitivity in Pancreatic Adenocarcinoma. Front Pharmacol 2022;13:937413. [DOI: 10.3389/fphar.2022.937413] [Reference Citation Analysis]
15 Herrera-Campos AB, Zamudio-Martinez E, Delgado-Bellido D, Fernández-Cortés M, Montuenga LM, Oliver FJ, Garcia-Diaz A. Implications of Hyperoxia over the Tumor Microenvironment: An Overview Highlighting the Importance of the Immune System. Cancers (Basel) 2022;14:2740. [PMID: 35681719 DOI: 10.3390/cancers14112740] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Pu Y, Ji Q. Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression. Front Immunol 2022;13:874589. [PMID: 35592338 DOI: 10.3389/fimmu.2022.874589] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
17 Qiao X, Xue L, Huang H, Dai X, Chen Y, Ding H. Engineering defected 2D Pd/H-TiO2 nanosonosensitizers for hypoxia alleviation and enhanced sono-chemodynamic cancer nanotherapy. J Nanobiotechnology 2022;20:186. [PMID: 35413839 DOI: 10.1186/s12951-022-01398-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Liu Y, Chen T, Gu N, Yang F. Recent progress in bioactive gas delivery for cancer immunotherapy. Prog Biomed Eng 2022;4:022001. [DOI: 10.1088/2516-1091/ac4c43] [Reference Citation Analysis]
19 Vahidfar N, Farzanefar S, Ahmadzadehfar H, Molloy EN, Eppard E. A Review of Nuclear Medicine Approaches in the Diagnosis and the Treatment of Gynecological Malignancies. Cancers 2022;14:1779. [DOI: 10.3390/cancers14071779] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Nakajima K, Homma M, Suzuki M, Yokouchi Y, Matsuda T, Takakura H, Hirata K, Kuge Y, Ogawa M. Reduction of tumor hypoxia by anti-PD-1 therapy assessed using pimonidazole and [18F]FMISO. Nuclear Medicine and Biology 2022. [DOI: 10.1016/j.nucmedbio.2022.03.005] [Reference Citation Analysis]
21 Gomes ER, Franco MS. Combining Nanocarrier-Assisted Delivery of Molecules and Radiotherapy. Pharmaceutics 2022;14:105. [PMID: 35057001 DOI: 10.3390/pharmaceutics14010105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Jiang ZY, Liu JB, Wang XF, Ma YS, Fu D. Current Status and Prospects of Clinical Treatment of Osteosarcoma. Technol Cancer Res Treat 2022;21:15330338221124696. [PMID: 36128851 DOI: 10.1177/15330338221124696] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Sato A, Kraynak J, Marciscano AE, Galluzzi L. Radiation therapy: An old dog learning new tricks. Radiation Oncology and Radiotherapy Part A 2022. [DOI: 10.1016/s0091-679x(22)00139-x] [Reference Citation Analysis]
24 Álvarez-abril B, Bloy N, Galassi C, Sato A, Jiménez-cortegana C, Klapp V, Aretz A, Guilbaud E, Buqué A, Galluzzi L, Yamazaki T. Cytofluorometric assessment of acute cell death responses driven by radiation therapy. Radiation Oncology and Radiotherapy Part A 2022. [DOI: 10.1016/bs.mcb.2022.05.002] [Reference Citation Analysis]
25 Xu J, Zai W, Ye Q, Zhang Q, Yi W, Wu J. A nitroreductase responsive and photoactivated fluorescent probe for dual-controlled tumor hypoxia imaging. RSC Adv 2022;12:23796-800. [DOI: 10.1039/d2ra04004b] [Reference Citation Analysis]
26 Tschanz F, Bender S, Telarovic I, Waller V, Speck RF, Pruschy M. The ADAM17-directed Inhibitory Antibody MEDI3622 Antagonizes Radiotherapy-induced VEGF Release and Sensitizes Non–Small Cell Lung Cancer for Radiotherapy. Cancer Research Communications 2021;1:164-177. [DOI: 10.1158/2767-9764.crc-21-0067] [Reference Citation Analysis]
27 Qin B, Jiang M, Li X, Shi Y, Zhang J, Luo Z, Luo L, Lu Y, Liu X, Wang S, Du Y, Qiu Y, Lou Y, You J. Oxygen nanocarrier broke the hypoxia trap of solid tumors and rescued transfection efficiency for gene therapy. J Nanobiotechnology 2021;19:427. [PMID: 34922537 DOI: 10.1186/s12951-021-01144-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]